bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione
Targeting the Vulnerability of Glutathione Metabolism in ARID1A Deficient Cancers ScienceDirect BSO is an inhibitor of gamma glutamylcysteine synthetase (gamma GCs), Download Scientific Diagram Pro Oxidant Auranofin and Glutathione Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal glutathione synthesis regulation Scheme representing the biosynthesis and mechanism of of Glutathione Dependent Pathways in Cancer Cells
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




